Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000675

Drug Information
Synonyms2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine; 2-methyl-3-[[(2R)-pyrrolidin-2-yl]methoxy]pyridine; Pozanicline; CID127922; 161417-03-4; AC1L2SVN; Pozanicline (USAN); Abt-089; PDSP2_001311; Pyridine, 2-methyl-3-(2-pyrrolidinylmethoxy)-, (R)-; CHEMBL126692; CHEMBL127071; AC1L434V; D09367; PDSP2_001310; PDSP1_001327; Pyridine, 2-methyl-3-((2S)-2-pyrrolidinylmethoxy)-; CID178052; UNII-CL2002R563; PDSP1_001326; 2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine; ABT 089; 161417-20-5; 2-Methyl-3-(2S-pyrrolidinylmethoxy)pyridine; CHEBI:309696; (R)-2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine; Pyridine, 2-methyl-3-(2-pyrrolidinylmethoxy)-, (S)-; A 94224; CHEBI:310037
CompanyAbbott Laboratories
IndicationAttention-defi cit/hyperactivity disorder, schizophrenia, anxiety and dementia
[ICD9: 290-294, 295, 300, 314.0   ICD10: F01-F07, F20, F40-F42, F90]
Discontined in Phase II    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC1=C(C=CC=N1)OCC2CCCN2    
CAS NumberCAS 161417-03-4
PubChem Compound IDCID 178052.
PubChem Substance IDSID 755276.
TargetNicotinic acetylcholine receptorAgonist[1]
Ref 1Emerging drugs for attention-deficit/hyperactivity disorder. Expert Opin Emerg Drugs. 2007 Sep;12(3):423-34. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543